John Cavan

Insider Reports History

Entity
Individual
Location
C/O Stemline Therapeutics, Inc., 750 Lexington Avenue, 6 Th Floor, New York, NY
Signature
/s/ John Cavan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Cavan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Hepion Pharmaceuticals, Inc. Chief Financial Officer Stock Options 1.58M May 18, 2021 Direct

Insider Reports Filed by John Cavan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HEPA Hepion Pharmaceuticals, Inc. May 18, 2021 1 $0 4 May 20, 2021 Chief Financial Officer